The effect of pessary usage in the treatment of prolapse of pelvic organs.

Comparison of quality of life in women with pelvic organ prolapse before and after using pessary

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016072618311N2

Enrollment

Registered

2016-08-31

Start date

2016-08-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolapse Of Pelvic Organs. Prolapse Of Pelvic Organs

Interventions

Intervention group: Put a pessary into the vagina, Made in America, mylex brand, Approved by America FDA.

Rehabilitation

Intervention group: Put a pessary into the vagina, Made in America, mylex brand, Approved by America FDA

Eligibility

Sex/Gender

Female

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Women with pelvic organ prolapse symptoms; Women between 40 to 80 years Exclusion criteria:Patients with malignant problems of women; asthma; heart disease and risk for surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Urinary Symptoms. Timepoint: Before intervention; three months afte rintervention; three months afte rintervention. Method of measurement: Pelvic Organ Prolapse Quantification System (POP–Q).	—

Secondary

Measure	Time frame
Quality of life. Timepoint: Before treatment, three months and six months after treatment. Method of measurement: questionnaire (Incontinence quality of life =I-QOL).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvin Bastani Alamdari

Tabriz University Of Medical Sciences

lahroudin@gmail.com+98 41 3553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026